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Abstract: Incorporation of fisetin, quercetin and kaempferol in beta cyclodextrins was proved 
by scanning electron microscopy (SEM), differencial scanning calorimetry (DSC) and X-ray 
powder diffraction (XRPD). Pure compounds and their complexes were tested for 
antiproliferative and pro-apoptotic activity on the B164A5 murine melanoma cell line and for 
the antimicrobial properties on the selected strains. The phytocompounds present in a different 
manner in vitro chemopreventive and weak antimicrobial activity. Incorporation in beta 
cyclodextrins had a mix effect on the biological activity conducing to decrease, increase or 
consistent effect compared to pure phytocompound, depending on the screened process and on 
the chosen combination. 
Keywords: Fisetin, quercetin, kaempferol, beta- cyclodextrins, chemopreventive, antimicrobial.  
1. INTRODUCTION 
 Natural compounds and their chemical derivatives have 
represented among years invaluable sources of both consecrated 
and new therapeutic agents [1]. Accordingly to a recent report of 
WHO (World Health Organization) over 80% of world’s 
populations is using total plant extracts or isolated phytocompounds 
for their primary health care needs (www.who.int). Flavonoids 
represent one of the most studied classes of phytocompounds. 
Studies in the field show their role in the prevention of degenerative 
diseases including cancers, cardiovascular and neurodegenerative 
diseases [2]. From the chemical point of view flavonoids comprise 
a large group of polyphenolic compounds having in common a 
benzo-γ-pyrone structure [3]. Flavonols are an important subclass 
of flavonoids that have a 3-hydroxyflavone backbone [4]. They can 
be found in an increased number of vegetables and fruits. Statistics 
have shown that in western population the range value for the 
intake of flavonols varies between 2–50 mg per day [5, 6]. Fisetin, 
quercetin and kaempferol are among the prominent representatives 
of this class. 
 Fisetin can be found in strawberries, apples, persimmons, 
mangoes, kiwi, peach, lotus root, onions, cucumbers and other 
fruits and vegetables [7]. It was reported to prevent Alzheimer's 
disease in case of transgenic mice [8]. The flavonol was also 
depicted for its anti-oxidant, anti-cancer, anti-angiogenic, anti-
inflammatory, anti-diabetic neuroprotective and neurotrophic 
effects [9-11]. It supports ERK-dependent long-term potentiation  
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and enhances memory [12]. Fisetin showed also chemopreventive 
properties against human colon cancer cells HCT116 [13]. Addition 
of fisetin to cisplatin proved to be a good therapeutic strategy for 
the elimination of embryonal carcinoma cells [14]. 
 Quercetin can be found in apples, grapes, red wine, blue and 
black berries, red cherries, citrus, green leafy vegetables, onions, 
cocoa, tea [15]. It was described as an antioxidant, antiproliverative 
and antiangiogenic agent [16, 17]. Quercetin supports cardio- 
vascular health, blocks human platelet aggregation and eicosanoid 
synthesis [18]. It decrease blood pressure in animal models and 
humans [19]. It has been depicted as an anti-inflammatory agent by 
inhibiting STAT-1 and NF-κB activations [20]. Quercetin was 
found to block the release of substances involved in allergies and to 
inhibit mast cell secretion [21]. It was also reported as a 
chemopreventive agent on a wide number of cancers with very 
good results on prostate and colon cancers [22-24]. 
 Kaempferol can be found in apples, grapes, blackberries, 
peaches, green tea, tomatoes, potatoes, onions, green leafy vegetables 
[25]. Epidemiological studies have shown a positive correlation 
between consummation of nutraceuticals containing kaempferol and 
a decreased risk of developing several disorders such as cardio- 
vascular diseases and cancer [26]. In vitro and in vivo studies have 
shown a wide range of biological properties for this flavonol including 
anti-oxidant, chemo-preventive, cardio-preventive, anti-microbial, 
anti-angiogenic, neuroprotective, antidiabetic, anti-osteoporotic, 
anti-allergic properties [26-28]. Kaempferol have proved to have 
anticancer effects in case of : breast, ovarian, gastric, pancreatic, 
colorectal, bladder, prostate, lung cancer and leukemia [27, 29]. 
 Solubility may play an important role in the therapeutic efficacy 
of flavonols. It is well known that in general flavonoids and in this 
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water solubility [3]. This parameter can cause problems in terms of 
bioavailability of this active agents. Various approaches have been 
used throughout time in order to modify the dissolution profile of 
these lipophilic phytocompounds without changing the molecular 
structure, including: particle size reduction, complexation, use of 
lipid based system, use of surfactant of delivery in dosage form, 
incorporation in different types of micro or nano particles, pH 
modification, solid dispersion, crystal modification [30]. Cyclodextrins 
(CD’s) have been intensively used in the pharmaceutical field in 
order to increase the solubility, stability, safety and bioavailability 
of a wide range of molecules [31, 32]. From the chemical point of 
view CD’s are a family of cyclic oligosaccharides with the ability to 
form host-guest inclusion complexes with a wide variety of 
molecules, having a hydrophilic outer surface and a lipophilic 
central cavity.β CD’s are naturally occurring CD’s and contain 7 
glucopyranose units [31, 33]. 
 The aim of this study is to proof that the three flavonols can be 
successfully incorporated in β CD’s (beta-cyclodextrin (BCD) and 
hydroxylpropyl-beta-cyclodextrin (HPBCD)) in order to increase 
their water solubility. A second aim is to evaluate the antimicrobial 
effect, respectively the antiproliferative and pro apoptotic activity 
on the B164A5 murine melanoma cell line of pure flavonols and 
their complexes. 
2. MATERIALS AND METHODS 
2.1. Reagents 
 Fisetin, kaempferol, and quercetin were acquired from Sigma 
Aldrich (purity ≥98%). Beta-cyclodextrin (BCD) and hydroxylpropyl-
beta-cyclodextrin (HPBCD) were acquired from Cyclolab Hungary. 
All substances were used as received and stored as indicated by the 
manufacter. 
2.2. Complexes Preparation 
 For the preparation of the inclusion complexes the fallowing 
steps where employed: simple powder mixing, using a mortar and a 
pestle;kneading with a 50% (w/w) water : ethanol solution until the 
bulk of solvent evaporated and a paste-type product was formed; 
the mixture was then dried at room temperature for 24 hours and 
put in the oven, at 105 ºC, for several hours until reaching constant 
weight. The final product was pulverized and sieved. All the binary 
products were prepared using a molar ratio of 1:2 active substance : 
CD (MwFisetin =286.23 g/mol, MwKaempferol = 286.23 g/mol, Mw 
Quercetin = 302.236 g/mol, MwBCD= 1134.98 g/mol, MwHPBCD= 
1396 g/mol ). The molar ratio of 1:2 was chosen in order to achieve 
a better water solubility for active phytocompounds. 
2.3. Scanning Electron Microscopy (SEM) 
 The morphology of the particles was examined by SEM 
(Hitachi S4700, Hitachi Scientific Ltd., Tokyo, Japan). A sputter 
coating apparatus (Bio-Rad SC 502, VG Microtech, Uckfield, UK) 
was applied to induce electric conductivity on the surface of the 
samples. The air pressure was 1.3-13.0 mPa. 
2.4. Differencial Scanning Calorimetry (DSC) 
 The DSC measurements with a Mettler Toledo DSC 821e 
thermal analysis system with the STARe thermal analysis program 
V6.0 (Mettler Inc., Schwerzenbach, Switzerland), approximately 2–
5 mg of pure drug or product was examined in the temperature 
range between 25 oC and 350 oC. The heating rate was 10 oC min-1. 
Argon was used as carrier gas, at a flow rate of 10 l/h during the 
DSC investigation. 
2.5. X-ray Powder Diffraction (XRPD) 
 XRPD spectra were recorded with a BRUKER D8 Advance X-
ray diffractometer (Bruker AXS GmbH, Karlsruhe, Germany) 
system with Cu Kα1 radiation (λ = 1.5406 Å) over the interval 5-
30°/2. The measurement conditions were as follows: target, Cu; 
filter, Ni; voltage, 40 kV; current, 40 mA; time constant, 0.1 s; 
angular step 0.010°. In the determination of the degree of 
crystallinity, the total area of the three peaks with largest intensity 
was examined, after smoothing and background removal 
2.6.1. Cell Culture 
 B16 4A5 murine melanoma cell line (Sigma-Aldrich Company, 
Ayrshire, UK) was cultured in complete growth medium for these 
cells, containing Dulbecco’s Modified Eagle’s Medium (DMEM; 
Gibco BRL, Invitrogen, Carlsbad, CA, USA), supplemented  
with 10% fetal calf serum (FCS; PromoCell, Heidelberg, Germany), 
1% Penicillin/Streptomycin mixture (Pen/Strep, 10,000 IU/ml, 
FCS; PromoCell), and 2% HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid; Gibco BRL). The cells were cultured 
and expanded in standard conditions, at 37 °C and 5% CO2 
atmosphere. Medium replacement was performed every third day 
and, upon reaching 80% to 90% confluence, the cells were passed 
using 0.25% Trypsin-EDTA (ethylenediaminetetraacetic acid) solution 
(Sigma-Aldrich Company) followed by centrifugation (10 minutes, 
300 x g) and were replated in T75 culture flasks at a density of 
10,000 cells/cm2 to ensure optimal growth and expansion. 
2.6.2. MTT Assay 
 B16 4A5 murine melanoma cell line was seeded onto a 96-well 
culture plate at a cellular density of 10,000 cells/well and attached 
to the bottom of the well overnight. After 24 hours, 100 µL of new 
medium containing Dulbecco’s Modified Eagle’s Medium 
(DMEM; Gibco BRL, Invitrogen, Carlsbad, CA, USA) and 100 µM 
of the tested substances (dissolved in dimethyl sulfoxide – DMSO; 
Sigma-Aldrich Company) were added and incubated for 72 h; the 
medium was supplemented with 10% fetal calf serum (FCS; 
PromoCell, Heidelberg, Germany) and 1% Penicillin/Streptomycin 
mixture (Pen/Strep, 10,000 IU/ml; PromoCell, Heidelberg, 
Germany). The melanoma cells were then assayed by the addition 
of 10 µL of 5 mg/mL MTT solution from the MTT-based in vitro 
toxicology assay kit (Tox-1; Sigma-Aldrich Company). The intact 
mitochondrial reductase converted and precipitated MTT as blue 
crystals during a 4 h contact period. The precipitated crystals were 
dissolved in 100 µL of lysis solution provided by the manufacturer 
(Sigma-Aldrich Company). Finally, the reduced MTT was 
spectrophotometrically analyzed at 570 nm, using a microplate 
reader (Bio-Rad, Hercules, CA, USA); wells with untreated cells 
were considered as reference for viability, while DMSO, which was 
used to prepare stock solutions of the tested substances, was also 
added on the cells for evaluation of cellular proliferation. All in 
vitro experiments were carried out on two microplates in 
quadruplicates for each substance tested and controls. 
2.6.3. Annexin V-PI Assay 
 For evaluation of fisetin, quercetin, kaempferol, and their CD 
complexes effects on B164A5 melanoma cells, these cells were 
seeded on 6-well culture plates at a cellular density of 10,000 
cells/cm2. The tested substances were added in culture media at a 
concentration of 100 µM and left to interact for 72 hours. Annexin 
V-FITC (Miltenyi Biotec, Gladbach, Germany) was used in cell 
death flow cytometric studies (apoptosis) combined with propidium 
iodide staining solution (BD Biosciences, San Jose, CA, USA) 
following the manufacturer’s protocol. Briefly, 106 cells were 
washed in 1 × Annexin V Binding Buffer (BD Pharmigen), 
centrifuged at 300 g for 10 min, resuspended in the same solution 
and incubated with 10 µL of Annexin V-FITC for 15 min in the 
dark. After washing the cells with 1 mL specific binding buffer and 
centrifugation, the cell pellet was resuspended in 500 µL binding 
buffer, and 1 µg/mL of PI solution was added immediately prior to 
analysis by flow cytometry. Acquisition of data was performed with 
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the Cell Quest Pro software (Becton-Dickinson) on a 2 laser-
capable flow cytometer (FACSCalibur; BD Biosciences), and data 
analyses used Flowing Software 2.5. 
2.7.1. In Vitro Antibacterial Activity 
 The selected compounds were screened for their antimicrobial 
activity against 11 bacterial strains: Bacillus cereus (ATCC 14579), 
Staphylococcus aureus (ATCC 25923), Streptococcus pyogenes 
(ATCC 19615), Streptococcus pneumoniae (ATCC 49619) 
Enterococcus faecalis (ATCC 29212), Escherichia coli (ATCC 
25922), Yersinia enterocolitica (ATCC 23715), Klebsiella pneumoniae 
(ATCC 700603), Proteus mirabilis (ATCC 25933), Pseudomonas 
aeruginosa (ATCC 27853), Candida albicans (ATCC 10231) by 
the agar disk-diffusion method. 
2.7.2. Disk Diffusion Method 
 The antimicrobial activity of the selected compounds was 
evaluated according to the guidelines of the National Committee for 
Clinical Laboratory Standards (NCCLS, 1997) using agar disk 
diffusion method,Performance Standards for Antimicrobial Disk 
Susceptibility Tests, Approved standard M2-A6. NCCLS recommends 
a bacterial suspension with a density equal to a 0.5 McFarland 
(which gives a final bacterial concentration of 1-2x108 CFU/ml). 
The Mueller-Hinton agar plates were inoculated with bacterial 
suspension using a sterile cotton swab. The same method was used 
also for Candida albicans but in this case the tested suspension was 
of 2,2 McFarland and the medium was Sabouraud. Solutions of the 
tested compounds were prepared in DMSO at a concentration of  
10 mM. Within 15 min after the plates were inoculated, sterile 
Whatman no.1 filter paper disks (6 mm in diameter) impregnated 
with the solution in DMSO of the test compounds were distributed 
evenly on the surface, with at least 30 mm (center to center) between 
them. For negative control we used paper disks impregnated with 
BCD and HPBCD. Plates inoculated with the bacterial suspensions 
were incubated at 37°C for 24h. The inhibition zone diameters were 
measured in millimeters, with a ruler. For all bacterial strains we 
performed duplicate disk-diffusion tests and average values are 
reported. 
2.8. Statistics 
 The Prism software package (Graph Pad Prism 4.03 for 
Windows) was used for data presentation. The experiment was 
repeated three times and results are presented as mean ± SD. One or 
two way ANOVA were applied to evaluate statistical significance 
(∗, p < 0.05; ∗∗, p < 0.01; and ∗∗∗, p < 0.001). 
3. RESULTS 
 SEM pictures are depicted in Fig. 1; one can notice the 
crystalline structure of all three natural compounds certified by the 
presence of defined crystal particles of various shapes and sizes. 
Also, beta-CD reveals crystalline character as proven by the 
irregular shaped particles in its composition; HPBCD is of 
amorphous nature, displaying round, partially broken particles with 
 
Fig. (1). Scanning electron microscopy (SEM) assay for: A) 1. Fisetin, 2. Kaempferol, 3. Quercetin B) Raw 1. BCD, 2. HPBCD ; C)1. Fisetin:BCD, 2. 
Fisetin:HPBCD; D) 1. Kaempferol:BCD, 2. Kaempferol:HPBCD; E) 1. Quercetin:BCD, 2. Quercetin:HPBCD 
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a clear tendency to aggregate. The beta-CD complexes revealed 
crystalline structures while the HPBCD based complexes show an 
amorphous composition of aggregated particles. 
 The DSC profiles of the natural flavonols, CD and 1:2 complexes 
are presented in Fig. 2. The two CD’s show an endothermic large 
peak below 100°C, specific for the loss of crystallization water 
molecules; above 100° C the two CD’s display a flat profile within 
the analysis temperature range thus certifying that the melting 
processes develop above 300°C. Fisetin (Fig. 2A) shows an 
endothermic sharp peak at 348°C consistent with its melting point; 
its complexes’ DSC profiles display flat curves which certify the 
 
Fig. (2). Differential scanning calorimetry (DSC) for: A) 1. Fisetin and it’s CD complexes; B) Kaempferol and it’s CD complexes; C) Quercetin and it’s CD 
complexes; D) Raw CD’s. 
 
Fig. (3). X-ray diffractograms for for: A) 1. Fisetin and it’s CD complexes; B) Kaempferol and it’s CD complexes; C) Quercetin and it’s CD complexes; D) 
Raw CD’s. 
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absence of thermal processes. For kaempferol (Fig. 2B) the melting 
process is revealed by the endothermic sharp peak at 286° C which 
disappears in the DSC profiles of its CD complexes. Fig. 2C displays 
the DSC curves for quercetin and its 1;2 complexes; one can notice 
the sharp endothermic peak at 321° C which characterizes the 
melting point of the pure compound; the DSC profiles of its 
complexes reveal the absence of thermal processes. 
 The X-ray diffractograms are showed in Fig. 3; one can notice 
that all three natural compounds display sharp signals, characteristic 
for crystalline materials; also, beta-CD has a crystalline structure as 
proven by the numerous distinct peaks in its diffractogram. HPBCD is 
an amorphous substance, characterized by almost flat diffractograms. 
The complexes containing beta-CD as host molecule display 
distinct sharp peaks, similar to the sum of individual components; 
however, the appearance of several new peaks as well as the 
shifting of others can be clearly noticed. The complexes of all three 
natural compounds with HPBCD are characterized by flat X-ray 
profiles similar to the corresponding CD. 
 
Table 1. Antimicrobial activity on the selected strains for: A) 1. 
Fisetin and it’s CD complexes; B) Kaempferol and it’s CD 
complexes; C) Quercetin and it’s CD complexes; D) Raw 
CD’s; E) Control. 
A) F F:BCD  F:HPBCD 
Escherichia coli  6mm 6mm 6mm 
Klebsiella pneumoniae 6mm 6mm 6mm 
Proteus mirabilis 6mm 6mm 6mm 
Yersinia enterocolitica 6mm 6mm 6mm 
Pseudomonas aeruginosa 6mm 6mm 6mm 
Bacillus cereus 6mm 6mm 6mm 
Streptococcus pneumoniae 11mm 15mm 10mm 
Streptococcus pyogenes 15mm 13mm 17mm 
Staphylococcus aureus  14mm 18mm 18mm 
Enterococcus faecalis 19mm 15mm 11mm 
Candida albicans  6mm 6mm 6mm 
B) K K:BCD  K:HPBCD 
Escherichia coli  6mm 6mm 6mm 
Klebsiella pneumoniae 6mm 6mm 6mm 
Proteus mirabilis 6mm 6mm 6mm 
Yersinia enterocolitica 6mm 6mm 6mm 
Pseudomonas aeruginosa 6mm 6mm 6mm 
Bacillus cereus 12mm 9mm 17mm 
Streptococcus pneumoniae 11mm 11mm 12mm 
Streptococcus pyogenes 15mm 15mm 20mm 
Staphylococcus aureus  15mm 16mm 18mm 
Enterococcus faecalis 11mm 11mm 11mm 
Candida albicans  6mm 6mm 6mm 
C) Q Q:BCD  Q:HPBCD 
Escherichia coli  6 mm 6mm 6mm 
Klebsiella pneumoniae 6mm 6mm 6mm 
Proteus mirabilis  6mm 6mm 6mm 
Yersinia enterocolitica 6mm 6mm 6mm 
Pseudomonas aeruginosa 6mm 6mm 6mm 
Bacillus cereus 6mm 6mm 6mm 
Streptococcus pneumoniae 11mm 11mm 11mm 
Streptococcus pyogenes 15mm 19mm 15mm 
Staphylococcus aureus  15mm 15mm 15mm 
Enterococcus faecalis 15mm 13mm 11mm 
Candida albicans  6mm 6mm 6mm 
D) BCD  HPBCD 
Escherichia coli  6mm 6mm 
Klebsiella pneumoniae 6mm 6mm 
Proteus mirabilis 6mm 6mm 
Yersinia enterocolitica 6mm 6mm 
Pseudomonas aeruginosa 6mm 6mm 
Bacillus cereus 6mm 6mm 
Streptococcus pneumoniae 6mm 6mm 
Streptococcus pyogenes 6mm 6mm 
Staphylococcus aureus  6mm 6mm 
Enterococcus faecalis 6mm 6mm 
Candida albicans  6mm 6mm 






Escherichia coli  19 mm 6mm 6mm 
Klebsiella pneumoniae 18mm 6mm 6mm 
Proteus mirabilis 16mm 6mm 6mm 
Yersinia enterocolitica 17mm 6mm 6mm 
Pseudomonas aeruginosa 18mm 6mm 6mm 
Bacillus cereus 18mm 6mm 6mm 
Streptococcus pneumoniae 9mm 16mm 6mm 
Streptococcus pyogenes 9mm 16mm 6mm 
Staphylococcus aureus  18mm 6mm 6mm 
Enterococcus faecalis 6mm 19mm 6mm 
Candida albicans  6mm 6mm 19mm 
 
 Additionaly the study analyzed the antimicrobial potential of 
the three flavonols: fisetin, quercetin and kaempferol alone and 
incapsulated in beta-cyclodextrin (BCD) and hydroxylpropyl-beta-
cyclodextrin (HPBCD). The strains include: gram negative bacteria 
(Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, 
Yersinia enterocolitica, Pseudomonas aeruginosa), gram positive 
bacteria (Bacillus cereus), gram positive cocci (Streptococcus 
pyogenes, Streptococcus pneumoniae, Staphylococcus aureus, 
Enterococcus faecalis) and fungus (Candida albicans). Gentamicin 
10 µg was used as positive control for bacillus and staphylococcus, 
gentamicin 120 µg was used as positive control for streptococci and 
enterococci and fluconazol 25 µg was used as positive control for 
fungus. For controls diameters were between 16-19 mm. Results are 
presented in Table 1. A 6 mm diameter show no antibacterial 
activity. The selected compounds present a weak antibacterial 
activity against gram positive cocci. The gram negative bacteria and 
fungus are resistant at this agents. Slight inhibition could be 
detected for the gram positive bacteria Bacillus cereus but only in 
case of kaempferol and it’s CD’s complexes. For all three active 
agents, complexation with the three beta CD’s increased the 
antibacterial activity different depending on the bacterial strain. For 
fisetin in case of S. pneumoniae the best activity was recorded after 
incorporation in BCD, for S. pyogenes after incorporation in 
HPBCD, for S. aureus both complexes presented a better 
antibacterial activity while in case of E. faecalis both complexes 
decreased the antibacterial activity compared to pure fisetin. For 
kaempferol in case of S. pneumoniae the best activity was recorded 
after incorporation in HPBCD, for S. pyogenes after incorporation 
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in HPBCD for S. aureus after incorporation in BCD and HPBCD. 
In case of E. faecalis the complexes had the same antibacterial 
activity compared to pure kaempferol. From the tested flavonols 
only kaempferol and it’s CD’s complexes presented antibacterial 
activity against the gram positive bacteria Bacillus cereus, and in 
this case the best activity was detected after incorporation in 
HPBCD. For quercetin in case of S. pneumoniae and S. aureus the 
complexes had the same antibacterial activity compared to pure 
compound. For S. pyogenes the best activity was recorded after 
incorporation in BCD while for E. faecalis complexation in all three 
cases decreased the antibacterial activity compared to pure 
quercetin. Results are presented in Table 1. 
 Morphological aspect of reference/control B164A5 cells shows 
polygonal shape, clustering tendency and intense direct contact 
between cells. The cells are grouping and make variable size 
placards. When treated with fisetin, quercetin, kaempferol and their 
CD’s complexes, the cells lose their polygonal shape and become 
more fusiform, stretching for contact with the neighboring cells. 
The grouping tendency is reduced, and we can see single cells very 
often on the microscopic field, more or less, depending on the 
tested substance. Results are presented in Fig. 4. 
 The antiproliferative activity of the tested flavonols and their 
CD’s complexes on B164A5 murine melanoma cell line is rather 
poor. Among the three tested compounds after 72 h of incubation 
 
Fig. (4). A) Morphological aspects of control/reference and DMSO-treated cells. 1. Control cells; 2. DMSO-treated cells for 72 hours, Ob. 4x. B) 
Morphological aspects of cells treated with CD in vitro for 72 hours. 1. BCD; 2. HPBCD, Ob. 4x. C)Morphological aspects of cells treated with Fisetin and its 
CD complexes in vitro for 72 hours. 1. Pure substance; 2. BCD complex of Fisetin; 3. HPBCD complex of Fisetin., Ob. 4x. D) Morphological aspects of cells 
treated with Quercetin and its CD complexes in vitro for 72 hours. 1. Pure substance; 2. BCD complex of Quercetin; 3. HPBCD complex of Quercetin. Ob. 4x. 
E) Morphological aspects of cells treated with Kaempferol and its CD complexes in vitro for 72 hours. 1. Pure substance; 2. BCD complex of Kaempferol; 3. 
HPBCD complex of Kaempferol. Ob. 4x 
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and at a concentration of 100 µM, quercetin showed the strongest 
antiproliferative activity, the mean value for the viability of cells 
being 51,2 ±14,14, fallowed by fisetin with 71,5 ±10,60 viable cells  
and kaempferol with 88,6±16,26 viable cells. Encapsulation of this 
active agents in beta cyclodextrins did not have a significant 
activity in terms of increasing the antiproliferative activity. For 
fisetin the viability was sensitive reduced for both CD complexes. 
In case of kaempferol the viability was sensitive reduced for the 
HPBCD complex, while for the BCD complex the viability was 
slightly increased. Quercetin was the flavonol whose complexs 
acted really different, namely the BCD complex decreased the 
viability and the HPBCD complex significant increased the 
viability of B164A5 murine melanoma cells. Results can be 
observed in Fig. 5. 
 The Annexin-PI double staining show that after a period of 
incubation of 72 h at a concentration of 100 µM all three flavonols 
conduced to early and late phenomena of apoptosis. The effects 
where quite close however, kaempferol was the most active in 
terms of early apoptotic events with a percentage of 26,55±8,48 
early apoptotic cells, fallowed by fisetin with a percentage of 
21,42±7,19 early apoptotic cells and quercetin with a percentage of 
18,4±4,24 early apoptotic cells. Regarding the late apoptotic events 
results are quite similar for the three tested compounds, namley : 
9,56±2,83 late apoptotic cells after incubation with fisetin, 
7,15±3,04 late apoptotic cells after incubation with kaempferol and 
5,54 ±4,87 late apoptotic cells after incubation with quercetin. 
Incorporation in beta cyclodextrins did not increased the number of 
early or late apoptotic cells for any of the three complexes. 
Representative plots of Annexin V-PI staining can be observed in 
Fig. 6 while mean of the three experiments can be observed in Fig. 7. 
4. DISCUSSIONS 
 The physico-chemical analysis use to demonstrate that 
incorporation took place, are very known “tools” in the 
pharmaceutical and biomedical field [34-36]. Scanning electron 
microscopy is a very useful technique to characterize the 
morphology of solid samples; although it cannot provide strict 
evidence in terms of complex formation the analysis offers reliable 
information in the assessment of the final products’ composition 
[37]. All three natural principles reveal a crystalline structure 
characterized by the presence of distinct particles, some of 
parallelepiped shape and similar size. Beta-CD is also composed of 
crystalline particles while HPBCD is an amorphous substances, 
displaying round particles that form bigger aggregates. The kneaded 
products reveal a significant change of structure; thus, beta-CD 
complexes are of crystalline nature, most particular when quercetin 
is involved. However, the aspect of individual particles is clearly 
different as compared to the pure compounds. The products 
obtained using HPBCD as host-molecules reveal an amorphous 
structure, similar to the pure cyclodextrins, thus leading to the 
conclusion that a solid state interaction took place. The presence of 
small particles in the final products together with the aggregation 
tendency is characteristic for single component amorphous samples 
[38]; therefore, one can assume that the complexation procedure led 
to the formation of true inclusion complexes. 
 Thermal analysis such as differential scanning calorimetry is 
currently involved in cyclodextrin complexes evaluation due to the 
valuable information it can provide [38]. In this regard, it has been 
established that following the inclusion process the normal thermal 
behavior of the guest-molecule changes significantly as a result to 
its accommodation inside the cyclodextrin’s cavity [33]. Analyzing 
the DSC profiles of the pure compounds and cyclodextrins versus 
the DSC profiles of the newly prepared complexes, one can notice 
that in all three cases the sharp peak indicating the melting point of 
the substance alone disappears as a result on 1:2 complexation; 
thus, the DSC profiles of the 1:2 products are practically identical 
to the curves recorded for the pure cyclodextrins. The 
disappearance of the endothermal processes characteristic for the 
pure compounds in the DSC profiles of 1:2 products is a reliable 
evidence of the total inclusion of the phytocompound inside the 
respective cyclodextrin. 
 In order to complete the evaluation of the 1:2 products the XRD 
analysis was perfomed; it usually provides significant information 
in terms of crystalline changes due to intermolecular interactions 
[39]. In the X-ray diffractograms of pure fisetin, kaempferol and 
quercetine, respectively, as well as beta-CD, the presence of sharp 
distinct peaks characterizes the crystalline nature of the compound. 
HPBCD revealed an amorphous nature as proven by the almost flat 
X-ray profiles. The 1:2 product of beta-CD with fisetin, kaempferol 
and quercetin, respectively, show crystalline characteristics; 
however one can notice the appearance of new peaks as well as the 
shifting in position of some existing individual peaks, thus proving 
the formation of a new crystalline phase. The presence of new 
peaks, of different position and intensity as compared to the 
individual compounds can be regarded as evidence of the formation 
of the inclusion complex. 
 The 1:2 products with HPBCD, exhibit an almost flat 
diffractogram, therefore an amorphous structure; this result can  
be regarded as a proof of complex formation but also of an 
amorphisation process that took place due to the kneading 
procedure. 
 The selected flavonols have been previously reported for their 
antimicrobial activity. Fisetin at the conc of 8 µg/mL was reported 
to inhibit the oral pathogen S. mutans. However no activity was 
recorded in case of P. gingivalis or E. coli [40]. It was depicted also 
as an antiviral agent against Dengue virus type-2 [41]. A recent 
study showed that fisetin inhibits L. monocytogenes virulence [42]. 
It was published that fisetin inhibit arginase, a central enzyme in L. 
amazonensis infection [43]. In vitro antifungal activity against H. 
courbaril was also described [44]. A range of seven kaempferol 
rhamnosides were reported for their antimicrobial activity against S. 
aureus, P. aeruginosa, S. typhi, C. albicans, C. parapsilosis and C. 
neoformans [45]. Kaempferol was found to inhibit herpes simplex 
virus, human coronavirus and rotavirus [46]. This flavonol showed 
synergic activity with clindamycin against Propionibacterium 
acnes [47]. Previous studies discuss that kaempferol did not inhibit 
E. coli and S. epidermidis but demonstrate antimicrobial activity 
against S. aureus [48]. Debating this results, the group of Panizzi et 
al., showed that kaempferol present no antimicrobial activity 
against S. aureus and E. coli [49]. The group of Hirai et al., screen 
the antibacterial activity of quercetin against gram-positive and 
gram-negative bacteria. The flavonol was found to be selective on 
 
Fig. (5). Viability (%) of B164A5 mouse melanoma cells after 72 h of 
incubation with 100 µM of Fisetin (F), Kaempferol (K) and Quercetin (Q) 
and their cyclodextrin complexes. 
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Fig. (6). Representative plots of Annexin V-PI staining. A)1. Control/reference untreated cells; 2. Cells treated with the highest amount of DMSO used for 
preparing stock solution of the tested substances; B) 1. Cells treated with BCD; 2. Cells treated with HPBCD; C) 1. Fisetin; 2. BCD complex of Fisetin; 3. 
HPBCD complex of Fisetin; D) 1. Quercetin; 2. BCD complex of Quercetin; 3. HPBCD complex of Quercetin; E). 1. Kaempferol; 2. BCD complex of 
Kaempferol; 3. HPBCD complex of Kaempferol. 
 
Fig. (7). Mean of the three experiments of Annexin V-PI staining for A) Fisetin and it’s CD complexes (Two ways Anova-Interaction-p= 0.0404, Row factorp- 
> 0.9999,Colum factor p- < 0.0001); B) Quercetin and it’s CD complexes (Two ways Anova-Interaction-p= 0.0926, Row factor-p > 0.9999,Colum factor p- < 
0.0001); C) Kaempferol and it’s CD complexes (Two ways Anova-Interaction-p= 0.0232, Row factor-p > 0.9999,Colum factor-p < 0.0001) 
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S. aureus, Methicillin-resistant Staphylococcus aureus (MRSA) and 
S. epidermidis [50]. In addition, new quercetin-derived oxidation 
products presented antibacterial activity against H. pylori and 
MRSA strains [51]. The phytocompound was evaluated also for it’s 
antimicrobial activity against pathogens of the main oral infectious 
diseases and was found to be very efficient against S. mutans, S. 
sobrinus, A. actinomycetemocomitans [52]. The uptake and recognition 
by specific cellular receptors and transport systems for different 
types of cyclodextrins have been previously discussed [53]. The 
group of Lehner et al., showed that for liphophilic compounds 
complexation with hydroxypropyl-beta-cyclodextrin leads to a 
stronger antimicrobial activity [54]. Increase antimicrobial activity 
after incorporation in BCD and HPBCD was reported also for 
cefdinir [55]. It was published that CD’s used as excipients in tooth 
pastes increase the availability of the antimicrobial agent triclosan 
[56]. The beneficial effects of complexation with beta-cyclodextrins 
were brought to light also for six antimycotic imidazole derivatives 
[57]. In a study of the group of Athanassiou et al. including several 
beta-lactam antibiotics it was proved that the activity of the 
cyclodextrin-included beta-lactam antibiotics was increased, 
particularly against gram-negative strains [53]. 
 As depicted in the results section we can stain that the three 
flavonols do not have a strong antiproliferative activity against 
B164A5 murinic melanoma cell line. Among the three compounds 
quercetin proved to be the best candidate, but the events could be 
seen at a high dose, namely 100 µM and after a long period of 
incubation, namely 72 h. On the other hand in terms of apoptosis, 
using the same conditions the effects where quite close for the three 
flavonols. The explanation could point towards the different 
mechanism that this natural compounds have for chemoprevention, 
targeting the mitochondrial dehydrogenase enzyme for anti- 
proliferative activity or the mithocondrial regulation or direct signal 
transduction for triggering apoptosis. The group of Zhang et al. 
have shown that quercetin induces apoptosis against B16-BL6 cell 
line by targeting mitochondria, inhibiting expression of PKC-alpha 
and translocating PKC-delta [58]. In association with tamoxifen, 
quercetin was described to sensitize human melanoma cells to 
hyperthermia [59]. A recent study have shown that the mechanism by 
which quercetin exerts anti-melanoma effect involves the inhibition 
of STAT3 signaling [60]. This information was completed by the 
group of Cao et al., who showed that the phytocompound inhibits 
HGF/c-Met signaling and HGF-stimulated melanoma cell invasion 
and migration [61]. In vivo, using the B16-BL6 model it was also 
proved to inhibit melanoma growth and metastatic potential [62]. 
Fisetin was reported to be an active agent against human melanoma 
cells by targeting MAPK and NFκB signaling pathways and by 
promoting the mesenchymal to epithelial transition [63]. The 
studies regarding the mechanism of action where completed by the 
group of Syed et al. who have showed that fisetin acts as an anti-
melanoma compound through direct binding to p70S6K and mTOR 
[64]. Kaempferol was described with anti-inflammatory and 
depigmenting effect [65]. It was shown that it regulates the cyclin-
dependent kinases CDK2 and CDK1 in vitro for human melanoma 
OCM-1 cell line [66]. It was also showed to inhibit melanogenesis 
in B164A5 melanoma cell line [67]. Cyclodextrin encapsulation did 
not have any spectacular effect for none of the three phyto 
chemicals concerning both proliferation and apoptosis. Research in 
the field have shown that for some active compounds this kind of 
modulations can increase the in vitro chemopreventive activity by 
higher cellular uptake and transfection efficiency [68, 69]. However 
the discussion can suffer intense debate because some papaers in 
the field report increased in vitro chemopreventive activity after 
incorporation in beta-cyclodextrins, others have noticed no change 
or even decreased chemopreventive activity after this kind of 
modulation [70-72]. 
5. CONCLUSION 
 The three flavonols: fisetin, quercetin and kaempferol  
were successfully incorporated in beta-cyclodextrin (BCD) and 
hydroxylpropyl-beta-cyclodextrin (HPBCD). The phytocompounds 
present in a different manner in vitro antiprolifrative and pro-
apoptotic activities on the B164A5 murinic melanoma cell line and 
weak antimicrobial activity on the selected strains. Incorporation in 
beta cyclodextrins had a mix effect on the biological activity 
conducing to decrease, increase or consistent effect compared to 
pure phytocompound depending on the screened process and on the 
chosen combination. 
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